Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
FDA To End Program That Hid Millions Of Reports On Faulty Medical Devices
In the wake of a KHN investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.
Short-Staffed Nursing Homes See Drop In Medicare Ratings
In its latest update to the Nursing Home Compare website, the government gave 1,638 homes its lowest star rating for staffing — one star on its five-star scale. Most were downgraded because payroll records reported no registered-nurse hours at all for at least four days.
Even Doctors Can’t Navigate Our ‘Broken Health Care System’
A physician’s frustration navigating a medical emergency with his elderly father reveals a complex, dysfunctional system.
Watch: Electronic Medical Records Investigation In Spotlight On C-SPAN
KHN’s Fred Schulte talks on C-SPAN with viewers about errors and other problems with computerized health records.
Is Insulin’s High Cost Keeping Diabetes Patients From Taking Their Medicine?
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
Will Ties To A Catholic Hospital System Tie Doctors’ Hands?
Doctors at the University of California’s flagship San Francisco hospital are sharply divided over a proposal to join forces with a Catholic-run system that restricts care on the basis of religious doctrine — part of a broader public debate as Catholic hospitals expand their reach.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Newsom: California Leads On Prescription Drugs
A leader but not the leader.
Klobuchar Wants To Stop ‘Pay-For-Delay’ Deals That Keep Drug Prices High
It’s as shady as it sounds.